With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.
According to MarketsandMarketstm, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...
Veteran genomics leader joins Illumina to advance global medical strategyIllumina chief commercial officer to depart for role as a life science tools company CEO SAN DIEGO, Jan. 8, 2026 /PRNewswire/ ...
Zacks Investment Research on MSN
Three genomics stocks worth tracking this year
An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...
Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the ...
Discover GRAIL’s MCED screening tests, Illumina’s divestiture impact, and an $8B valuation base with TAM upside tied to FDA ...
Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help ...
What Is Driving the Updated Illumina Price Target? Illumina's fair value estimate has been revised from about US$119.84 to ...
The company unveiled the appointment alongside news of the departure of its chief commercial officer.
Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...
Add Yahoo as a preferred source to see more of our stories on Google. Illumina's headquarters in San Diego. Illumina has named Eric Green as chief medical officer, providing a home to the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results